首页|Max-Planck-Institute for Biochemistry Reports Findings in Personalized Medicine (Bridging the Gap from Proteomics Technology to Clinical Application: Highlights from the 68th Benzon Foundation Symposium)
Max-Planck-Institute for Biochemistry Reports Findings in Personalized Medicine (Bridging the Gap from Proteomics Technology to Clinical Application: Highlights from the 68th Benzon Foundation Symposium)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of a report.According to news reporting fr om Martinsried, Germany, by NewsRx journalists, research stated, “The68th Benzo n Foundation Symposium brought together leading experts to explore the integrati on of massspectrometry (MS)-based proteomics and artificial intelligence in rev olutionizing personalized medicine.This report highlights key discussions on re cent technological advances in MS-based proteomics, includingimprovements in se nsitivity, throughput, and data analysis.”
MartinsriedGermanyEuropeArtificial IntelligenceDrugs and TherapiesEmerging TechnologiesMachine LearningPer sonalized MedicinePersonalized TherapyProteomicsTechnology
NETL
NSTL
